Does DENOSUMAB Cause Injection site erythema? 162 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 162 reports of Injection site erythema have been filed in association with DENOSUMAB (Bilprevda). This represents 0.1% of all adverse event reports for DENOSUMAB.
162
Reports of Injection site erythema with DENOSUMAB
0.1%
of all DENOSUMAB reports
2
Deaths
16
Hospitalizations
How Dangerous Is Injection site erythema From DENOSUMAB?
Of the 162 reports, 2 (1.2%) resulted in death, 16 (9.9%) required hospitalization, and 4 (2.5%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 162 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which DENOSUMAB Alternatives Have Lower Injection site erythema Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE